Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $9.55 and traded as low as $9.39. Viemed Healthcare shares last traded at $9.44, with a volume of 226,688 shares changing hands.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on VMD. Weiss Ratings lowered Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Wall Street Zen downgraded Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Finally, Barrington Research began coverage on Viemed Healthcare in a research report on Monday, August 24th. They issued an “outperform” rating and a $14.00 target price for the company. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Viemed Healthcare currently has a consensus rating of “Hold” and a consensus target price of $14.00.
View Our Latest Stock Analysis on Viemed Healthcare
Viemed Healthcare Trading Down 2.4%
The firm’s 50-day moving average is $9.24 and its 200 day moving average is $9.55. The company has a current ratio of 1.13, a quick ratio of 1.02 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $359.55 million, a price-to-earnings ratio of 26.22, a P/E/G ratio of 2.42 and a beta of 1.04.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last posted its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. The business had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. On average, equities analysts predict that Viemed Healthcare, Inc. will post 0.41 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Viemed Healthcare
A number of hedge funds have recently modified their holdings of VMD. BlackRock Inc. acquired a new stake in Viemed Healthcare in the second quarter valued at $54,587,000. Nantahala Capital Management LLC acquired a new position in Viemed Healthcare during the 2nd quarter worth about $7,209,873. Punch & Associates Investment Management Inc. acquired a new position in Viemed Healthcare during the 2nd quarter worth about $6,082,000. Raffles Associates LP acquired a new position in Viemed Healthcare during the 2nd quarter worth about $4,602,000. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after buying an additional 358,863 shares during the period. Institutional investors and hedge funds own 74.24% of the company’s stock.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.
The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.
Further Reading
- Five stocks we like better than Viemed Healthcare
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
